HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F D Bohmer Selected Research

6,7-dimethoxy-3-phenylquinoxaline

10/2002Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor.
7/2001Inhibition of FLT3-mediated transformation by use of a tyrosine kinase inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F D Bohmer Research Topics

Disease

2Leukemia
10/2002 - 07/2001

Drug/Important Bio-Agent (IBA)

26,7-dimethoxy-3-phenylquinoxalineIBA
10/2002 - 07/2001
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2002
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
07/2001